ARK Investment Management - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$5,461,542
+10.5%
775,787
-4.1%
0.04%
+5.9%
Q1 2023$4,942,782
-5.7%
808,966
-1.3%
0.03%
-24.4%
Q4 2022$5,238,931
-76.4%
819,864
-64.6%
0.04%
-71.0%
Q3 2022$22,199,000
+12.0%
2,317,217
-21.1%
0.16%
+32.5%
Q2 2022$19,816,000
-60.8%
2,935,679
-3.4%
0.12%
-44.5%
Q1 2022$50,573,000
-63.2%
3,037,443
-57.8%
0.21%
-49.3%
Q4 2021$137,477,000
-52.1%
7,201,518
-38.2%
0.42%
-39.7%
Q3 2021$287,285,000
-40.2%
11,649,837
-36.9%
0.69%
-22.7%
Q2 2021$480,088,000
-23.1%
18,450,713
-6.5%
0.89%
-28.0%
Q1 2021$624,546,000
-12.0%
19,726,650
+29.0%
1.24%
-34.3%
Q4 2020$709,819,000
+172.8%
15,297,822
+93.6%
1.89%
+22.4%
Q3 2020$260,177,000
+123.8%
7,903,308
+86.6%
1.54%
+23.4%
Q2 2020$116,258,000
+337.8%
4,235,273
+377.4%
1.25%
+88.8%
Q1 2020$26,558,000
+16.5%
887,179
+7.8%
0.66%
+15.1%
Q4 2019$22,790,000
+53.7%
823,344
+1.0%
0.58%
+77.5%
Q3 2019$14,829,000
-25.1%
814,796
+0.9%
0.32%
-35.1%
Q2 2019$19,805,000
+201.2%
807,688
+16.8%
0.50%
+165.4%
Q1 2019$6,576,000
+2.3%
691,494
-4.8%
0.19%
-28.0%
Q4 2018$6,428,000
+34.5%
726,360
+71.0%
0.26%
+81.2%
Q3 2018$4,779,000
+204.4%
424,820
+246.4%
0.14%
+148.3%
Q2 2018$1,570,000
+42.7%
122,623
+88.4%
0.06%
+5.5%
Q1 2018$1,100,00065,0960.06%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MHR Fund Management 19,997,103$90,986,81911.15%
MPM BioImpact LLC 3,287,397$14,957,6563.99%
Perceptive Advisors 11,962,938$54,431,3671.82%
CM Management, LLC 200,000$910,0000.97%
Velan Capital Investment Management LP 250,000$1,137,5000.92%
Opaleye Management Inc. 610,000$2,775,5000.90%
Boxer Capital, LLC 3,705,133$16,858,3550.90%
SECTORAL ASSET MANAGEMENT INC 985,000$4,481,7500.87%
Parametrica Management Ltd 95,400$434,0700.73%
683 Capital Management, LLC 2,050,000$9,327,5010.72%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders